Cadiz Inc. Declares Quarterly Dividend for Q1 2024 on Series A Cumulative Perpetual Preferred Stock
LOS ANGELES, March 22, 2024 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI/CDZIP) ("Cadiz," the "Company") today announced that its Board of...
Month: March 2024
Cadiz Inc. Declares Quarterly Dividend for Q1 2024 on Series A Cumulative Perpetual Preferred Stock
LOS ANGELES, March 22, 2024 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI/CDZIP) ("Cadiz," the "Company") today announced that its Board of...
BTCS Reports 2023 Results
2023 Record Net Income of $7.8m or $0.55 per shareSilver Spring, MD, March 22, 2024 (GLOBE NEWSWIRE) -- BTCS Inc....
Automotive Accessories Manufacturer Selects Bridgeline for AI-Powered Search
WOBURN, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a marketing technology company, announced today that...
Foresight Reports Successful POC Completion
DENVER, Colo., Mar 22, 2024 (247marketnews.com)- Foresight Autonomous Holdings (NASDAQ:FRSX) reported, this morning, that its wholly owned subsidiary, Eye-Net Mobile,...
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
WEST DES MOINES, Iowa, March 22, 2024 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of...
Star Equity Holdings, Inc. Announces 2023 Fourth Quarter and Full Year Financial Results
Ended 2023 with cash and cash equivalents of $18.9 millionGenerated positive cash flow from operations of $2.7 million in 2023Read more at...
Star Equity Holdings, Inc. Announces 2023 Fourth Quarter and Full Year Financial Results
Ended 2023 with cash and cash equivalents of $18.9 millionGenerated positive cash flow from operations of $2.7 million in 2023Read more at...
SINTX Technologies Announces Proposed Public Offering of Common Stock
SALT LAKE CITY, UT, March 22, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an...
VA STAND Act introduced in the United States Senate
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the...
Lumentum Thought Leaders to Present on Leading Edge Innovations and the Role of Photonics in AI Data Centers at OFC 2024
President and CEO Alan Lowe to discuss industry trends during the Optica Executive Forum CEO Panel Contacts Investors: Kathy Ta,...
Foresight: Eye-Net and Softbank Corp. Successfully Complete Technology Validation Phase for Connected Mobility Applications in Japan
As a result of the successful completion of the POC, the parties will initiate sales efforts with SoftBank's key business...
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology...
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally...
Norwood Financial Corp Announces Cash Dividend
HONESDALE, Pa., March 22, 2024 (GLOBE NEWSWIRE) -- James O. Donnelly, President and Chief Executive Officer of Norwood Financial Corp...
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
Oak Ridge, TN, March 22, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
SAN DIEGO, March 22, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage...
A2Z Smart Technologies Corp. Announces First Deployment of New Generation Smart Carts
TEL AVIV, ISRAEL / ACCESSWIRE / March 22, 2024 / A2Z Smart Technologies Corp. ("A2Z" or the "Company") (Nasdaq:AZ), a...
AGM Announces Establishment of Canadian Subsidiary, Accelerating Global Business Expansion
BEIJING, March 22, 2024 /PRNewswire/ -- AGM Group Holdings Inc. ("AGMH" or the "Company") (NASDAQ: AGMH), an integrated technology company...
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
Contacts Investor & Media Inquiries Louise Wilkie ir@sangamo.com media@sangamo.com Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced...
Rumble’s Founder and CEO Chris Pavlovski to Hold a Live Stream via Rumble Studio with Matt Kohrs
LONGBOAT KEY, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the video-sharing platform...
REE Automotive Announces Date for Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
TEL AVIV, Isreal, March 22, 2024 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive...
NaaS Technology Inc. to Report 2023 Fourth Quarter and Full Year Unaudited Financial Results on March 28, 2024 Eastern Time
BEIJING, March 22, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging...
Inspired Launches Virtual NFLA Lottery Product End Zone Cash With the Pennsylvania Lottery
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B...
Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells...
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
Contacts Investor Contact Michael Moore Vice President, Investor Relations & Corporate Communications 619-302-4431 ir@equilliumbio.com Equillium, Inc. (Nasdaq: EQ), a clinical-stage...
Med Holdings Group, Inc. (FKA Yuka Group, Inc.) Announces Acquisition Of Medsmart Wellness Centers, Inc.
DENVER, CO / ACCESSWIRE / March 22, 2024 / (OTC Pink:YUKA) Med Holdings Group, Inc. (FKA Yuka Group, Inc.)(the "Company")...
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
ISELIN, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the...
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the...
Ispire Technology Announces Pricing of $12.3 Million Public Offering
LOS ANGELES, March 22, 2024 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a leader in the research...
Murano Global begins Trading Today as MRNO
DENVER, Colo., Mar 22, 2024 (247marketnews.com)- Murano Global Investments Plc. completed its business combination with HCM Acquisition Corp (NASDAQ:HCMA) and...
HYZON ANNOUNCES FOURTH QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Announces first commercial delivery of fuel cell electric truck in the U.S. BOLINGBROOK, Ill., March 22, 2024 /PRNewswire/ -- Hyzon...
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
Transitioning HBV cure programs into multiple late-stage combination studies with interim results throughout 2024 and 2025 informing Company's registrational strategy...
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
Transitioning HBV cure programs into multiple late-stage combination studies with interim results throughout 2024 and 2025 informing Company's registrational strategy...
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
Transitioning HBV cure programs into multiple late-stage combination studies with interim results throughout 2024 and 2025 informing Company's registrational strategy...
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
The QuantideX® qPCR BCR-ABL IS Kit is now compliant with the latest diagnostic regulations in Europe MINNEAPOLIS, March 22, 2024...
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
LONDON and NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
-Biologics License Application (BLA) for HAV™ Accepted by FDA on February 8, 2024--BLA Granted Priority Review for Vascular Trauma Indication;...
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
NEW YORK and VIENNA, Austria, March 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing...
Biolase Reports Financial Results and Projects Further Revenue Growth for 2024
DENVER, Colo., Mar 22, 2024 (247marketnews.com)- BIOLASE, Inc. (NASDAQ:BIOL) reported, after yesterday’s market close, its fourth quarter and full year...